Endpoints News’ Post

Isn’t it funny how speaking to a new audience about a new topic can turn even the calmest person into a nervous wreck? At the Biotech Summit Austria, I had the golden opportunity to step up and wow the audience with just five minutes to show our dedication to young biotech startups. I was there to highlight our benefits for founders and investors, and, oh yes, to squeeze in a mention of our products and services. Easy, right? Ha! 😅 I mean, everyone else was unveiling cool tech or life-saving drugs, while I just hoped not to trip or bore the audience the last minutes before lunch… Honestly, my nerves were dancing to their own rhythm. But here’s the turning point: after a few days with the pitch behind me, I’ve realized that my flustered state was completely misplaced! All those brilliant minds in tech and science are incredible, no doubt! But so are we, when it comes to patient safety and compliance - like superheroes with capes made of SOPs and compliant batch releases! 🤣 I may have underestimated my own worth that day, but I’m embracing it now for every opportunity that comes my way. So, here’s to the glorious realization of our worth! Thanks for the moment of brilliance. 🎉Confetti🎉 And as I mentioned in my last post, this event had more influence on me than just the obvious stuff! So, let’s keep riding this wave of self-discovery together, even if we get a little soggy along the way! If you have made any similar experience, please let me know 👍 #BSA24 #pitch #my_nerves_do_what_they_want

After a productive networking break in the Great Room Foyer, we now have the “Medtech by the Numbers” Panel Session, moderated by Jennifer McMahon, Partner at Seroba.: • Inga D. Deakin, Principal, Molten Ventures • Megan MacDonagh, Vice President, SV Health Investors • Anne Portwich, Partner, EQT Life Sciences  • Sylvain Sachot, Partner, Asabys Partners 2023 life science investment went down across the board, in biotech and medtech equally, but in diagnostics and healthtech to a greater degree. A panel of European VCs discusses what’s in store for 2024. The number of up-rounds is down, which is a negative for VC firms supporting early-stage companies. The situation needs to change in order to reward early investment, the lifeblood of medtech innovation. We are seeing a lot of structured deals, option deals with many milestones. It does look good when a strategic is interested in a company, and it provides a path for exit. But it is a two-sided sword.   Remain informed on new articles, conference updates and more with our helpful medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

If you are evaluating funding partners, check out the Bullpen Inning 1 interviews, including this one from Salvatore Buscemi!

Hey startup founders, if you're looking for a comprehensive guide to help you navigate the entrepreneurial journey, you've got to check out this post! Don't miss out on this valuable resource! #startup #entrepreneurship #businessguide

More interesting thoughts from Darwin Ling in the Bullpen Inning 1.

I was excited to join the LifeArc Translational Science Summit yesterday to explore how I can support new companies scaling operations and improving efficiency to accelerate bringing medicines to market. A great opportunity for networking and staying current. #LifeArc #Consultancy #NetworkingOpportunity 🚀💼✨ 🔬 Biotech ventures morning sessions🔬 The UK’s biotech sector - Surveying the landscape and opportunities for growth  🌟 Claire Terlouw (LifeArc) and Steve Bates OBE FMedSci (BioIndustry Association (BIA)) led a discussion on the impact of the BIA within the life science sector. Hearing firsthand accounts of crisis management scenarios navigated through the BIA reaffirms its critical role in our industry. Successfully navigating challenges like the R&D tax credits debacle and the Silicon Valley Bank collapse is truly inspiring. #LifeArc #BIA #LifeScience 💡🔬 Financial Strategies for the future – funding innovative life science companies  🚀 We moved to the world of financing strategies. Led by Claire Terlouw (LifeArc) with Arthur Franken (Gilde Healthcare), Neil White (Yosemite), Eliot Charles (SR One Capital Management), and Luc Dochez (Droia Ventures). My key takeaways :   💼 Learning about diverse investor types, tailored investment strategies, and the crucial balance of risks in decision-making. From technical to financial considerations, every aspect matters.   💡 Embrace rejections as learning opportunities, building resilience for future success in the competitive investment landscape. #InvestmentStrategies #ResilienceBuilding 📈 The CEO war room   🌟 A session led by Imran Hamid (LifeArc) who was joined by Hakim Yadi (Closed Loop Medicine), Mike Westby (RQ Biotechnology Limited), and Natalie Mount (Abingworth) who shared their war stories, lessons learned, and tips for aspiring entrepreneurs.  My key takeaways: 🚀 Embrace feedback..... even a 'no' decision will provide valuable learnings.  🤝 Understand the evolving role of the board and the importance of building trust and relationships. #EntrepreneurshipJourney #LessonsLearned #CEO #Feedback #Trust💡 I’ll share the afternoon sessions tomorrow! #LATSS2024 Great to see some familiar faces too Natalie Francis, Claudia Montiel Equihua, Nigel Huscroft, Ian Catchpole, Kathryn Chapman,

Hey startup founders, if you're looking for a comprehensive guide to help you navigate the entrepreneurial journey, you've got to check out this post! Don't miss out on this valuable resource! #startup #entrepreneurship #businessguide

Hope you listen (or forward) to the end of the video because I share something I think is especially important to say right now. We’re just over 2 weeks away from thousands of innovators, investors, strategics, and more joining together at the Epicenter of Medtech in Dana Point, CA. A couple updates... 1. Partnering is cranking and investors are getting assertive (great to see) We just cracked 1,000 partnering meetings and growing fast. Expecting over 5,000 meetings this year. Let's get some deals done. If you're an attending investor or strategic and want more info on the 325 presenters, send Andrew Stadnick an email (his details are in the comments) 2. LSI Alumni Virtual Incision & Arga Medtech with big wins this week Congrats to Virtual Incision on their FDA Authorization for MIRA Surgical System this week. Tip of the hat to their investors (also LSI Alumni) Endeavour Vision and cultivate(MD). Congrats to Arga Medtech on closing a €54 Million round. And another hat tip to their investors (also LSI Alumni) Gilde and Early Bird. 3. Panel celebrating Startup Nation Excited to spotlight Israel’s thriving innovation and investment ecosystem while highlighting their crucial role in Medtech and Healthtech globally during a timely session, “Israel: Past, Present & Future of Medtech Innovation in StartUp Nation.” See you in Dana Point.

Hey startup founders, if you're looking for a comprehensive guide to help you navigate the entrepreneurial journey, you've got to check out this post! Don't miss out on this valuable resource! #startup #entrepreneurship #businessguide